Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

132
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
132
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

144
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
144
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

108
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
108
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

144
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
144
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

289
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
289
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

380
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
380

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.

Frontiers in medicine·2024
Same author

Acta pharmaceutica Sinica. B·2024
Same author

Assessing psychometric properties and measurement invariance of the Sleep Quality Questionnaire among healthcare students.

BMC psychology·2024
Same author

Sema3A secreted by sensory nerve induces bone formation under mechanical loads.

International journal of oral science·2024
Same author

Sleep quality and subjective well-being in healthcare students: examining the role of anxiety and depression.

Frontiers in public health·2024
Same author

Exosomes Derived from hucMSCs Primed with IFN-γ Suppress the NF-κB Signal Pathway in LPS-Induced ALI by Modulating the miR-199b-5p/AFTPH Axis.

Cell biochemistry and biophysics·2024

関連する実験動画

Updated: Apr 16, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

38.6K

ディメリック薬物ポリマーナノ粒子は,薬物の負荷が非常に高く,定量的負荷効率が非常に高い.

Kaimin Cai1, Xi He1,2, Ziyuan Song1

  • 1†Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.

Journal of the American Chemical Society
|March 6, 2015
PubMed
まとめ

研究者は,50%以上の薬物負荷と定量的効率を持つポリマーナノ粒子 (NP) を作成するための新しい戦略を開発しました. このブレークスルーは,強化された薬物投与システムのための二次元薬物結合コアを使用しています.

さらに関連する動画

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.9K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.2K

関連する実験動画

Last Updated: Apr 16, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

38.6K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.9K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.2K

科学分野:

  • ポリマー化学のポリマー化学について
  • ナノテクノロジー ナノテクノロジー ナノテクノロジー
  • 薬物の配達 薬物の配達

背景:

  • ポリマーナノ粒子 (NP) は,小分子薬の封装に広く使用されています.
  • 現在の方法は,薬物の負荷と効率が低いことがよくあります.
  • 薬物のペイロード能力を改善した先進的なNP製剤が必要である.

研究 の 目的:

  • 薬物の負荷と定量的負荷効率が非常に高いポリマーNPの準備のための新しい戦略を開発する.
  • NPsのコア構成ユニットとして二次元薬物結合体を設計する.
  • 開発されたNPの安定性と放出特性を調査する.

主な方法:

  • 二次性薬物結合体とメトキシポリ (エチレングリコール) -ブロックポリラクチド (mPEG-PLA) の共降.
  • 立体薬核とポリマー殻を持つNPの形成.
  • 薬物の負荷,負荷効率,生理学的条件における安定性,および誘発された薬物の放出の評価.

主要な成果:

  • 非常に高い薬物負荷 (>50%) と定量的負荷効率を達成しました.
  • 生理学的条件 (PBS溶液) でNPの優れた安定性を示した.
  • 外部から誘発され,早期に放出されない状態で,本物の薬剤形態の制御された放出を展示した.

結論:

  • 開発された戦略により,薬物の負荷能力が著しく向上したポリメリックNPの製造が可能になります.
  • 立体薬物結合コア戦略は,安定した制御された薬物投与システムのための有望なアプローチを提供します.
  • これらの高薬物負荷のNPは,効率的でトリガーされた治療剤の放出を必要とするアプリケーションに適しています.